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Frontotemporal dementia (FTD) and Alzheimer’s disease are sometimes difﬁcult to differentiate clinically because of overlapping
symptoms. Using diffusion tensor imaging (DTI) measurements of fractional anisotropy (FA) can be useful in distinguishing the
different patterns of white matter degradation between the two dementias. In this study, we performed MRI scans in a 4 Tesla
MRI machine including T1-weighted structural images and diffusion tensor images in 18 patients with FTD, 18 patients with
Alzheimer’s disease and 19 cognitively normal (CN) controls. FA was measured selectively in speciﬁc ﬁbre tracts (including
corpus callosum, cingulum, uncinate and corticospinal tracts) as well as globally in a voxel-by-voxel analysis. Patients with FTD
were associated with reductions of FA in frontal and temporal regions including the anterior corpus callosum (P<0.001),
bilateral anterior (left P<0.001; right P=0.005), descending (left P<0.001; right P=0.003) cingulum tracts, and uncinate
tracts (left P<0.001; right P=0.005), compared to controls. Patients with Alzheimer’s disease were associated with reductions
of FA in parietal, temporal and frontal regions including the left anterior (P=0.003) and posterior (P=0.002) cingulum tracts,
bilateral descending cingulum tracts (P<0.001) and left uncinate tracts (P<0.001) compared to controls. When compared with
Alzheimer’s disease, FTD was associated with greater reductions of FA in frontal brain regions, whereas no region in Alzheimer’s
disease showed greater reductions of FA when compared to FTD. In conclusion, the regional patterns of anisotropy reduction in
FTD and Alzheimer’s disease compared to controls suggest a characteristic distribution of white matter degradation in each
disease. Moreover, the white matter degradation seems to be more prominent in FTD than in Alzheimer’s disease. Taken
together, the results suggest that white matter degradation measured with DTI may improve the diagnostic differentiation
between FTD and Alzheimer’s disease.
Keywords: Alzheimer’s disease; frontotemporal dementia; diffusion tensor imaging; diffusion tensor ﬁbre tracking
Abbreviations: CN=cognitively normal; Dax=axial diffusivity; Dra=radial diffusivity; DTI=diffusion tensor imaging;
FA=fractional anisotropy; FDR=false discovery rate; FTD=frontotemporal dementia; ICC=intraclass correlation coefﬁcients;
MMSE=Mini-Mental State Examination; ROI=regions of interest; TOI=tracts of interest; WMSH=white matter signal
hyperintensities
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Frontotemporal dementia (FTD), the behavioural variant of
frontotemporal lobar degeneration, is sometimes difﬁcult to clini-
cally differentiate from Alzheimer’s disease, due to overlapping
clinical symptoms (McKhann et al., 1984; Neary et al., 1998;
Siri et al., 2001). Structural (Kitagaki et al., 1998; Laakso et al.,
2000; Rosen et al., 2002; Gee et al., 2003) and functional
(Johnson et al., 1987; Miller et al., 1991; Julin et al., 1995;
Bartenstein et al., 1997; Pickut et al., 1997; Ishii et al., 1998;
Charpentier et al., 2000; Varma et al., 2002; Varrone et al.,
2002; Diehl et al., 2004; Grimmer et al., 2004; Kim et al.,
2005; McMurtray et al., 2006) neuroimaging studies have
shown characteristic differences of grey matter abnormalities
in FTD and Alzheimer’s disease. In FTD, MRI studies reported
regional patterns of grey matter atrophy in primarily frontal lobe
regions (Rosen et al., 2002; Perry et al., 2006; Whitwell et al.,
2006), similar to the regional patterns of functional changes mea-
sured by reduced cerebral blood ﬂow and glucose metabolism
from SPECT and PET studies, respectively (Jeong et al., 2005;
Coulthard et al., 2006; Diehl-Schmid et al., 2007). By comparison,
brain atrophy in Alzheimer’s disease is initially observed in medial
temporal lobe regions, whereas functional changes are more
prominent in the parietal lobe (including the posterior cingulate
gyrus and lateral parietotemporal areas). The frontal lobe regions
are generally spared in Alzheimer’s disease until late stages (see
review papers: Anderson et al., 2005; Drzezga, 2008; Ries et al.,
2008). New MRI ﬁndings have shown that both FTD (Cardenas,
et al., 2007; Chao et al., 2007) and Alzheimer’s disease (Double
et al., 1996; Teipel et al., 2002) can involve white matter loss.
However, the regional distribution of loss is difﬁcult to study
due to lack of discernable anatomical features of white matter in
conventional MRI.
Diffusion tensor imaging (DTI) has become the method of
choice for detecting white matter alterations in the human brain
(Le Bihan et al., 2001). DTI, which is sensitive to water diffusion,
captures microstructural alterations of tissue by measuring system-
atic directional changes in water diffusivity. The directionality of
diffusion is usually expressed as fractional anisotropy (FA), which
ranges from zero for isotropic diffusion to unity for diffusion
exclusively along one direction (Pierpaoli and Basser, 1996). For
example, well-organized (i.e. strongly myelinated) white matter
tracts have high-FA values because water diffuses more freely in
the direction of the axonal ﬁbre tracts, while diffusion perpendic-
ular to the ﬁbres is relatively restricted. As the ﬁbres degenerate,
diffusion becomes less directional and thus the value of FA
decreases. DTI has been used to study normal aging and a variety
of neurological diseases (Ellis et al., 1999; Yoshikawa et al., 2004;
Aoki et al., 2005; Shiga et al., 2005) including Alzheimer’s dis-
ease and FTD. In Alzheimer’s disease, DTI studies reported FA
reductions in a variety of white matter regions including the
posterior corpus callosum, posterior cingulum, fornix and bilater-
ally in the uncinate ﬁbres using regions of interest (ROI) analyses
(Rose et al., 2000; Bozzali et al., 2002; Takahashi et al., 2002;
Fellgiebel et al., 2004, 2005; Head et al., 2004; Sugihara et al.,
2004; Choi et al., 2005; Naggara et al., 2006; Taoka et al., 2006;
Huang et al., 2007; Ringman et al., 2007; Stahl et al., 2007;
Zhang et al., 2007; Yasmin et al., 2008). Other regionally
unbiased DTI studies of Alzheimer’s disease using voxel-by-voxel
analyses, have shown FA reductions in parietal and temporal lobe
regions as well as in the thalamus and internal capsule (Medina
et al., 2006; Xie et al., 2006; Teipel et al., 2007; Rose et al.,
2008). To this date, few DTI studies of FTD have reported
white matter damage. One study found FA changes in the
superior and the inferior longitudinal fasciculus (Borroni et al.,
2007) using a regionally unbiased analysis. Another study found
FA changes additionally in the uncinate ﬁbres and the genu of the
corpus callosum using ROI analysis (Matsuo et al., 2008).
Although these ﬁndings imply that the distribution of white
matter damage is different between FTD and Alzheimer’s disease,
no DTI study to our knowledge has directly compared DTI ﬁndings
in FTD with those in Alzheimer’s disease. Furthermore, compari-
sons of previous results are complicated by the fact that some DTI
studies used voxel-by-voxel tests (Medina et al., 2006; Xie et al.,
2006; Borroni et al., 2007; Teipel et al., 2007; Rose et al., 2008)
whereas others limited regional analyses to an a priori deﬁned
ROI, which was often guided by ﬁbre tracts (Taoka et al., 2006;
Matsuo et al., 2008; Yasmin et al., 2008). Although ROI can
provide anatomically reliable information, especially when com-
bined with tractography to guide the ROI, the approach requires
a priori hypotheses about regional distributions of alterations.
In contrast, voxel-wise analyses circumvent the regional bias
but are problematic with respect to the accurate alignment of
tract anatomy. Using both approaches together may provide
complementary information.
We employed both voxel-wise and tractography-guided ROI
tests in this study to compare white matter alterations in FTD
and Alzheimer’s disease. Our main objectives were: (i) to deter-
mine if FTD is associated with a characteristic regional pattern of
FA reduction––implying systematic white matter degradation––in
comparison to healthy elderly subjects; (ii) to replicate previous
ﬁndings of regional FA reductions in Alzheimer’s disease; and
(iii) to compare the regional patterns of FA reductions in FTD to
that of Alzheimer’s disease.
Subjects and Methods
Subjects
Eighteen FTD patients (mean age and standard deviation: 62.110.7
years) with a Mini-Mental State Examination (MMSE) (Folstein et al.,
1975) score of on average 24.14.7, 18 patients with Alzheimer’s
disease (age: 62.87.1 years; MMSE: 21.75.8) and 19 cognitive
normal (CN) subjects (age: 61.510.6 years; MMSE: 29.50.5) were
included in this cross-sectional MRI study. A summary of the subject
demographics and relevant clinical information is listed in Table 1.
The patients with FTD and Alzheimer’s disease were recruited from
the Memory and Aging Centre of the University of California,
San Francisco. All patients were diagnosed based upon information
obtained from an extensive clinical history and physical examination.
The MR images were used to rule out other major neuropathologies
such as tumours, strokes, severe white matter disease or inﬂammation
but not to diagnose dementia. The subjects were between 30- and
80-years old and without history of brain trauma, brain tumour,
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diseases that affect brain function. FTD was diagnosed according to
the consensus criteria established by Neary et al. (1998). All FTD
patients were diagnosed with the frontal variant subtype, two of
which had concurrent motor neuron-related symptoms. Patients with
Alzheimer’s disease were diagnosed according to the criteria of the
National Institute of Neurological and Communicative Disorders
and Stroke-Alzheimer’s Disease and Related Disorders Association
(NINCDS/ADRDA) (McKhann et al., 1984). All subjects received a
standard battery of neuropsychological tests including assessment of
global cognitive impairment by the MMSE score and global functional
impairment by the Clinical Dementia Rating (CDR) scale (Morris,
1993). The neuropsychological tests were not used for clinical diagno-
sis but rather to characterize the cognitive deﬁcits of the patients,
although a cognitive pattern of impaired executive functioning with
relatively well preserved memory and spatial ability was considered a
supportive feature of FTD. An experienced radiologist reviewed the
severity of white matter signal hyperintensities (WMSH) on MRI.
The severity of WMSH was classiﬁed as mild (score 1), moderate
(score 2) or severe (score >3), according to the Schelten’s rating
scale (Scheltens et al., 1993). All subjects or their guardians gave
written informed consent before participating in the study, which
was approved by the Committees of Human Research at the
University of California at San Francisco.
Data acquisition and processing
DTI was performed on a 4 Tesla (Bruker/Siemens) MRI system,
equipped with a birdcage transmit and eight channel receive coil.
DTI was based on a dual spin-echo echo-planar imaging (EPI)
sequence supplemented with parallel imaging acceleration (GRAPPA)
(Griswold et al., 2002) with a factor 2 to reduce susceptibility
distortions. Other imaging parameters were: TR/TE=6000/77ms;
ﬁeld of view 256224cm; 128112 matrix size, yielding
22mm
2 in-plane resolution; 40 continuous 3mm slices. A reference
image (no diffusion gradient b=0) and six diffusion-weighted images
(b=800s/mm
2 along six non-collinear directions) were acquired. Four
DTI scans were acquired and averaged after motion correction to
boost signal-to-noise. The total acquisition time of DTI was 4min.
Test–retest studies showed that measurement reproducibility of the
DTI protocol yielded intraclass correlation coefﬁcients (ICC) of 0.8
and higher in the vast majority of brain regions.
Maps of FA and mean diffusivity were computed using Volume-one
and dTV software (The software dTV is available via following
http://www.ut-radiology.umin.jp/people/masutani/dTV.htm) (Masutani
et al., 2003). In addition, axial diffusivity (Dax), which is equivalent to
the magnitude of the largest eigenvalues of the tensor (l1) and radial
diffusivity (Dra), which is the average of the other two eigenvalues
[(l2+l3)/2] were also calculated, supplementing the analysis of
FA. Image co-registration and spatial normalization for voxel-wise
statistical evaluations was conducted using SPM2 software (http://
www.ﬁl.ion.ucl.ac.uk/spm).
Tracts of interest measurements
Fibre tracking was performed with the Volume-one and dTV software
packages, which are based on the ﬁbre assignment by continuous
tracking (FACT) approach (Mori et al., 1999) to achieve a three-
dimensional tract reconstruction. The identiﬁcation of ﬁbres tracts
was initiated by placing a ‘Seed’ and a ‘Target’ area in anatomical
regions through which the particular ﬁbres are expected to propagate
as described by Wakana et al. (2004). The propagation of tracts was
constrained by a lower threshold of FA=0.18 and limits of angular
deviations from the path trajectory of <45. Trajectories that passed
through the Seed and Target were assigned to speciﬁc ﬁbre tracts
based on anatomical knowledge. Several major ﬁbre pathways were
selected due to their relations to higher brain functions. The tracts
included: (i) the cingulum tract, which is associated with memory
function, connects the anterior and posterior cingulate gyrus and
descends into the medial temporal lobe; (ii) the uncinate fascicules,
which is associated with memory and behavioural functions, connects
the inferior frontal lobe with the anterior medial temporal lobe; (iii) the
corpus callosum, which is associated with various functions depending
on the location along the corpus callosum, connects the brain
hemispheres; and (iv) the corticospinal tract, which is associated with
movement control, connects the primary motor cortex to the spinal
cord. Figure 1 depicts the placements of the Seed and Target area
for tracking these ﬁbres:
(i) Fibre tracking of the corpus callosum was performed by
placing the Seed on the mid-sagittal slice along the full
length of the corpus callosum (Fig. 1C);
(ii) Tracking of the cingulum ﬁbres, which are shorter and more
curved than the corpus callosum, was performed separately
for the upper and descending portions of these ﬁbres by
using two pairs of Seeds and Targets for each portion.
One pair was placed at the anterior and posterior terminal
of the cingulate regions. The other pair was placed at the
lower and higher ends of the parahippocampus (Fig. 1B);
(iii) Tracking of the uncinate ﬁbres was performed by placing
the Seed and Target on a coronal slice adjacent to the
most anterior point of the frontal and temporal terminal of
the uncinate tract (Fig. 1D);
(iv) Tracking of the corticospinal tract was performed by placing
the Seed on the cerebral peduncle and the Target on
the superior precentral gyrus and adjacent white matter
(Fig. 1A).
The reconstruction of the selected ﬁbres is illustrated in Fig. 2.
The ﬁbre tracts were then transformed into binary maps to guide
tracts of interest (TOI) measurements. The TOIs were further divided
into several portions according to anatomical location. For example,
the TOIs of the callosal ﬁbre tracts were divided into an anterior and a
posterior portion of the corpus callosum, such that the anterior corpus
callosum included mainly ﬁbres connecting to the frontal lobe and the
Table 1 Demographic and clinical summary
Cognitive
normal
Frontotemporal
dementia
Alzheimer’s
disease
Number of DTI 19 18 18
Age (years) 61.510.6 62.110.7 62.87.1
Age range (years) 33–73 32–77 51–74
Sex (M:F) 11:8 12:6 11:7
MMSE* 29.50.5 24.14.7 21.75.8
WMSH
(severe:moderate:
mild)
3:2:14 3:2:13 1:2:15
*MMSE scores in FTD and Alzheimer’s disease were signiﬁcant lower than in CN
(P<0.001), but not signiﬁcantly different between FTD and Alzheimer’s disease.
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on axial slice on the cerebral peduncle at the level of the decussation of the superior cerebellar peduncle; the Target (green colour) was
placed on an axial slice on the precentral gyrus (primary motor cortex), anterior to the central sulcus. (B) To deﬁne the upper part of
cingulum ﬁbres, Seed (red) and Target (green) were placed on the anterior and posterior cingulum areas on the same coronal slice level
as the genu and splenium of the corpus collosum, respectively. To deﬁne the descending part of cingulum, the Seed (red) and Target
(green) were placed as shown in the ﬁgure. (C) The deﬁnition of the callosal ﬁbre required only a single Seed (red) on a mid-sagittal
slice. (D) To deﬁne the uncinate fascicules, the Seed (red) and Target (green) were positioned on a coronal slice on the most posterior
slice where the frontal and temporal lobes appear separated.
Figure 2 Illustration of ﬁbre tracts of the corpus callosum (CC), cingulum (Cg), uncinate (Unc) and the corticospinal tract (CST) from a
single subject superimposed on a 3-dimensional FA image.
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and temporal lobes. Similarly, the cingulum ﬁbre tracts were divided
into three portions. The upper cingulum tract was separated into two:
(i) an anterior portion and (ii) a posterior portion, containing mainly
ﬁbres that connect to the anterior and posterior cingulate gyri, respec-
tively, while (iii) the third portion consisting of the descending
cingulum, which include mainly ﬁbres passing through the parahippo-
campus and the bottom of the temporal lobe. In total, six TOI pairs
were selected as illustrated in Fig. 3. For each TOI, the mean FA value
as well as mean Dax and mean Dra were computed for further analysis.
An experienced radiologist (Y.Z.), blinded to diagnosis, performed
the placements of the Seeds and Targets for tractography. To deter-
mine the reproducibility of tractography, the same rater performed
tractography twice, 2 months apart, on 12 randomly selected subjects.
Reproducibility was based on ﬁbre counts and expressed as ICC. An
ICC of 0.99 was achieved for the callosal ﬁbre tracking, 0.93 for
the cingulum, 0.95 for the uncinate and 0.96 for the corticospinal
tract tractography.
For the group analysis, we ﬁrst determined whether diagnosis
had a global effect on FA (or Dra, Dax) by multivariate analysis
of variance (MANOVA) that simultaneously included all TOIs. This was
followed by univariate post hoc tests of each TOI to determine local
effects. Age and gender were added as covariates. To account for mul-
tiple comparisons the signiﬁcance level was set to =0.01 for these tests.
Voxel-wise measurements
We also tested local effects on a voxel-by-voxel basis without con-
straints to the TOIs. For this approach, a study speciﬁc FA template
was created for the spatial normalization of the DTI data using SPM2.
First, each subject’s diffusion reference image (b0 image), which
generally provides sufﬁcient anatomical features, was transformed
into the EPI-derived MNI (Montreal Neurological Institute) template
in SPM by iterative non-linear transformations, yielding a mean
b0-image of the population. The same transformation parameters
were then applied to the corresponding FA maps to obtain a
customized mean FA image of the study population. Second, the FA
map of each subject was non-linearly transformed again, for spatial
normalization but this time to the customized FA template of the
population that was created in step one. To reduce effects of local
mis-registrations, the spatially normalized FA maps were smoothed
using an isotropic Gaussian kernel with a full width at half height
maximum of 4mm. Group comparisons were performed voxel-wise
by regressing the local FA intensity against diagnosis with adjustments
for age and sex. The concept of false discovery rate (FDR) was used to
control for multiple comparisons at a signiﬁcance level of =0.05
(Genovese et al., 2002). The voxel-wise analysis was considered
exploratory since image mis-registrations from spatial normalization
can mimic FA alterations especially, if brain atrophy is present. We
sought to control for effects from mis-registrations ﬁrst by using
FA=0.15 as lower threshold to avoid voxels in primarily CSF or grey
matter regions and second by using only voxels that all subjects had in
common. Similarly to FA, Dra and Dax images were also analysed
voxel-by-voxel. Although, these rules may not exclude all artefacts
from mis-registrations, the supplementary analysis based on TOI
should lend support to regionally unbiased ﬁndings.
Results
Demographics
Table 1 lists the demographics and clinical data of the subjects.
The groups did not differ by age (P>0.6, ANOVA) or gender
distribution (P>0.8, Chi-square). As expected, patients with
FTD and Alzheimer’s disease scored signiﬁcantly lower than CN
Figure 3 Illustration of location and coverage of TOI: anterior corpus callosum (a.CC), posterior corpus callosum (p.CC), anterior
cingulum (a.Cg), posterior cingulum (p.Cg), descending cingulum (d.Cg), uncinate tracts (Unc) and corticospinal tracts (CST).
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scores between patients with FTD and Alzheimer’s disease were
not signiﬁcant (P=0.16), irrespective of age. WMSH severity,
which is subdivided into mild, severe and moderate groups,
were similar between the groups (P=0.7).
TOI analysis
Group differences of regional FA values as a function of diagnosis
are summarized in Table 2. This was performed separately for
each TOI region and the corresponding results of Dax and Dra
are summarized in Tables 3 and 4. The results from the voxel-wise
analysis are also listed in the tables for comparison.
Compared to CN, patients with FTD had lower FA values in the
anterior corpus callosum (P<0.001), bilateral anterior cingulum
(left P<0.001; right P=0.005), bilateral descending cingulum
(left P<0.001; right P=0.003), and uncinate ﬁbres (left
P<0.001; right P=0.005). In most regions, the FA reductions cor-
respond to an increase of Dra and in some regions to an increase
of Dax as well. In particular, the increase of Dra between FTD and
Table 2 Group differences from TOI analysis of regional FA values as a function of diagnosis; the synopsis of the
ﬁndings from the voxel-wise analysis
Region TOI analysis
FA (mean±SD) P-values Voxel-wise analysis
CN FTD AD FTD<CN AD<CN FTD<AD
a FTD<CN AD<CN FTD<AD
b
a.CC 0.540.03 0.460.06 0.510.04 0.0002 NS 0.007 S NS S
p.CC 0.640.04 0.610.04 0.610.04 NS 0.02 NS S S NS
L.a.Cg 0.500.04 0.430.05 0.450.05 <0.0001 0.003 NS S NS S
R.a.Cg 0.410.03 0.370.04 0.390.05 0.005 NS NS S NS S
L.p.Cg 0.480.04 0.450.04 0.440.03 NS 0.002 NS S S NS
R.p.Cg 0.430.04 0.410.04 0.410.03 NS NS NS S NS NS
L.d.Cg 0.360.02 0.320.03 0.320.03 <0.0001 <0.0001 NS S S NS
R.d.Cg 0.390.03 0.350.05 0.340.04 0.003 0.0001 NS S NS NS
L.Unc 0.390.03 0.340.03 0.360.03 <0.0001 0.0004 0.04 S S S
R.Unc 0.380.04 0.330.05 0.360.04 0.005 NS 0.03 S S S
L.CST 0.520.03 0.520.03 0.530.03 NS NS NS NS NS NS
R.CST 0.580.02 0.570.04 0.580.03 NS NS NS NS NS NS
a No region showed signiﬁcant lower FA in Alzheimer’s disease when compared to FTD (AD<FTD).
b No region showed signiﬁcant lower FA in Alzheimer’s disease when compared to FTD (AD<FTD).
a.CC/p.CC=anterior/posterior corpus callosum; L.a.Cg/R.a.Cg=Left/Right anterior cingulum; L.p.Cg/R.p.Cg=Left/Right posterior cingulum; L.d.Cg/R.d.Cg=Left/Right
descending cingulum; L.Unc/R.Unc=Left/Right uncinate fasciculus; L.CST/R.CST=Left/Right corticospinal tract.
Table 3 Group differences from TOI analysis of regional radial diffusivity (Dra) values as a function of diagnosis; the
synopsis of the ﬁndings from voxel-wise analysis
Region TOI analysis
Dra (mean±SD) P-values Voxel-wise analysis
CN FTD AD FTD>CN AD>CN FTD>AD
a FTD>CN AD>CN FTD>AD
b
a.CC 0.700.09 0.930.21 0.770.10 0.0002 0.03 0.01 S S S
p.CC 0.570.06 0.640.10 0.650.09 0.01 0.004 NS S S NS
L.a.Cg 0.550.05 0.670.07 0.610.07 <0.0001 0.004 0.02 S S S
R.a.Cg 0.610.04 0.700.06 0.65 0.08 <0.0001 NS 0.03 S S S
L.p.Cg 0.550.05 0.590.05 0.600.05 0.008 0.002 NS S S NS
R.p.Cg 0.560.04 0.610.05 0.600.05 0.01 0.003 NS S S NS
L.d.Cg 0.660.06 0.810.15 0.810.12 0.001 <0.0001 NS S S S
R.d.Cg 0.620.06 0.740.14 0.780.16 0.003 0.0003 NS S S NS
L.Unc 0.690.04 0.840.12 0.770.07 <0.0001 <0.0001 0.01 S S S
R.Unc 0.680.06 0.890.21 0.750.09 <0.0001 0.01 0.002 S S S
L.CST 0.61 0.05 0.630.07 0.600.07 NS NS NS NS NS NS
R.CST 0.490.03 0.540.09 0.490.04 0.01 NS 0.02 S NS S
a No region showed signiﬁcant increased Dra in Alzheimer’s disease when compared to FTD (AD>FTD).
b No region showed signiﬁcant increased Dra in Alzheimer’s disease when compared to FTD (AD>FTD).
a.CC/p.CC = anterior/posterior corpus callosum; L.a.Cg/R.a.Cg = Left/Right anterior cingulum; L.p.Cg/R.p.Cg = Left/Right posterior cingulum; L.d.Cg/R.d.Cg = Left/
Right descending cingulum; L.Unc/R.Unc = Left/Right uncinate fasciculus; L.CST/R.CST = Left/Right corticospinal tract.
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ference was observed when using FA.
Patients with Alzheimer’s disease when compared to CN had
lower FA values in the left posterior cingulum (P=0.002), left
anterior cingulum (P=0.003), bilateral descending cingulum
(both P<0.001) and left uncinate (P<0.001) ﬁbres, which was
similar to FTD. The posterior corpus callosum showed a trend
(P=0.02) towards lower FA values in Alzheimer’s disease than in
CN. In most regions, the FA reductions correspond to an increase
of Dra and in some regions to an increase of Dax. These results
were similar to those found in comparing FTD and CN. Most
interestingly, Alzheimer’s disease had substantially increased Dra
values (P=0.004) in the posterior corpus callosum, in absence of
signiﬁcant changes in Dax and FA.
Compared to Alzheimer’s disease, patients with FTD had lower
FA values in the anterior corpus callosum (P=0.007) and also
showed a trend towards lower FA values in bilateral uncinate
ﬁbres (left P=0.04; right P=0.03). Interestingly, the signiﬁcant
difference in FA between FTD and Alzheimer’s disease in the
anterior corpus callosum disappeared for Dra and Dax. On the
other hand, Dra and Dax values in the right uncinate ﬁbres were
signiﬁcantly higher in FTD than Alzheimer’s disease (P=0.002 and
P=0.0002, respectively) whereas differences in FA were not
signiﬁcant. Alzheimer’s disease compared to FTD showed no
signiﬁcant reductions of FA, nor signiﬁcant increases of Dra and
Dax values.
Voxel-wise analysis
Regional FA reductions in patients with FTD and Alzheimer’s
disease relative to CN subjects, as well as FA differences
between patients with FTD and Alzheimer’s disease, are depicted
in Figs 4–6. Signiﬁcant FA reductions are superimposed on the FA
template to better visualize the anatomical locations. For
comparison, the TOI regions from the tractography-based analysis
are also superimposed on the FA template. For each TOI region
the corresponding ﬁndings from the voxel-wise analysis [signiﬁ-
cant (S) or not signiﬁcant (NS)] are also listed in Tables 2–4.
Compared to CN, patients with FTD had widespread FA
reductions bilaterally in frontal and temporal white matter. The
most signiﬁcant FA reductions involved the anterior corpus
callosum, bilateral anterior and descending cingulum and uncinate
ﬁbres. The thalamic radiation in the anterior limb of internal
capsule, bilateral superior longitudinal fascicules and part of the
posterior corpus callosum were also affected. In general, the
distributions of increased Dra and Dax values in FTD corresponded
to the distribution of decreased FA value. Furthermore, Dra and
Dax differences between FTD and CN were more widespread in
bilateral frontal and temporal lobe white matter, brain stem
and posterior cingulum as compared to FA differences.
Compared to CN, patients with Alzheimer’s disease had FA reduc-
tions bilaterally in parietal and temporal white matter as well as
in some frontal periventricular areas. Signiﬁcant FA reductions
included the posterior corpus callosum, left posterior cingulum,
left descending cingulum and bilateral uncinate ﬁbres. FA reductions
were also detected in a small part of the anterior limb of internal
capsule. Compared to FA, the distributions of Dra and Dax are
more widespread in Alzheimer’s disease, especially in parietal and
temporal regions as well as in frontal periventricular regions.
Compared to Alzheimer’s disease, patients with FTD had lower
FA values bilaterally in frontal white matter. Involvement included
inferior temporal white matter regions as well as anterior corpus
callosum, bilateral anterior cingulum and uncinate ﬁbres. Lower FA
values in FTD relative to Alzheimer’s disease were also detected in
bilateral superior longitudinal fascicules, and the anterior limb of
internal capsule. In general, the distributions of increased Dra and
Dax values in FTD were more widespread than the distribution
of reduced FA. This pattern was most prominent in frontal and
Table 4 Group differences from TOI analysis of regional axial diffusivity (Dax) values as a function of diagnosis; the
synopsis of the ﬁndings from voxel-wise analysis
Region TOI analysis
Dax (mean±SD) P-values Voxel-wise analysis
CN FTD AD FTD>CN AD>CN FTD>AD
a FTD>CN AD>CN FTD>AD
b
a.CC 1.870.12 2.090.18 1.970.09 <0.0001 0.007 0.02 S S S
p.CC 1.850.10 1.910.10 1.930.10 0.04 0.02 NS NS S NS
L.a.Cg 1.440.07 1.450.08 1.430.07 NS NS NS S NS NS
R.a.Cg 1.280.05 1.340.09 1.310.06 0.03 NS NS S NS NS
L.p.Cg 1.310.06 1.330.06 1.320.08 NS NS NS NS NS NS
R.p.Cg 1.220.04 1.240.06 1.240.07 NS NS NS NS NS NS
L.d.Cg 1.250.07 1.370.16 1.370.13 0.008 0.001 NS S S NS
R.d.Cg 1.210.07 1.310.17 1.340.18 0.04 0.004 NS S S NS
L.Unc 1.310.08 1.430.13 1.380.08 0.001 0.02 NS S S NS
R.Unc 1.290.06 1.510.19 1.340.06 <0.0001 0.03 0.0002 S S NS
L.CST 1.430.06 1.480.08 1.450.07 NS NS NS S NS NS
R.CST 1.350.05 1.390.06 1.360.04 NS NS NS S NS NS
a No region showed signiﬁcant increased Dax in Alzheimer’s disease when compared to FTD (AD>FTD).
b No region showed signiﬁcant increased Dax in Alzheimer’s disease when compared to FTD (AD>FTD).
a.CC/p.CC=anterior/posterior corpus callosum; L.a.Cg/R.a.Cg=Left/Right anterior cingulum; L.p.Cg/R.p.Cg=Left/Right posterior cingulum; L.d.Cg/R.d.Cg=Left/Right
descending cingulum; L.Unc/R.Unc=Left/Right uncinate fasciculus; L.CST/R.CST=Left/Right corticospinal tract.
Diffusion tensor imaging in FTD and Alzheimer’s disease Brain 2009: 132; 2579–2592 | 2585Figure 4 Rendered display of DTI changes (A) reduced FA (warm colours); (B) increased Dra (cool colours); (C) increased Dax (cool
colours) in FTD or Alzheimer’s disease compared with cognitively normal subjects, as well as direct comparisons between FTD and
Alzheimer’s disease.
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compared to FTD showed no region with signiﬁcantly lower FA,
nor signiﬁcantly higher Dra and Dax values.
Discussion
The main ﬁndings of this study are: (i) FTD is associated with FA
reduction in the anterior corpus callosum, bilateral anterior and
descending cingulum and uncinate ﬁbre tracts. A voxel-by-voxel
analysis showed even more widespread FA reduction in FTD which
involved frontal and temporal white matter regions, expanded to
parietal, and spared occipital white matter. (ii) In contrast,
Alzheimer’s disease is associated with FA reduction in bilateral
descending cingulum, left posterior and anterior cingulum, and
left uncinate ﬁbre tracts, which is in agreement with previous
DTI studies. (iii) A direct comparison between FTD and Alzheimer’s
disease reveals that FTD is associated with lower FA values than
Alzheimer’s disease in frontal ﬁbres including the anterior corpus
callosum, and bilateral uncinate ﬁbres. By contrast, Alzheimer’s
disease shows no signiﬁcant regional FA reductions relative to
FTD. Furthermore, most FA reductions are related to increased Dra
and some to increased Dax values. Taken together, the different
regional patterns of DTI in FTD and Alzheimer’s disease compared
to CN suggest a characteristic distribution of white matter degrada-
tion for each disease. FTD is shown to be associated with more
extensive white matter degradation than Alzheimer’s disease.
The ﬁndings suggest that frontal and temporal white matter
regions are particularly vulnerable in individuals diagnosed with
FTD. These regions include: the anterior corpus callosum, which
contains ﬁbres connecting to frontal cortex; bilateral anterior and
the descending cingulum, which connect to the major limbic cor-
tices including anterior cingulate gyrus and hippocampus and bilat-
eral uncinate ﬁbres, which connect the frontal and inferior
temporal cortices. This regional pattern of FA reduction overlaps
with the pattern of white matter atrophy that we have previously
reported with structural MRI studies (Cardenas, et al., 2007; Chao
et al., 2007). Patterns of grey matter atrophy and hypoperfusion
have also been reported in FTD (Rosen et al., 2002; Jeong et al.,
2005; McMurtray et al., 2006; Seeley et al., 2008). Taken
together, these ﬁndings suggest that degradation of the white
matter ﬁbre bundles occurs in association with white matter loss
and cortical abnormalities in FTD. Therefore, white matter changes
are a major pathological characteristic of FTD (Larsson et al.,
2000, 2004). The DTI ﬁndings of white matter vulnerability in
FTD are most likely due to the axonal degeneration associated
Figure 5 Coronal view of the regional FA reductions between groups in anterior brain: the top row indicates regions of the tracts of
interest (TOIs) analysis for comparison with the voxel-wise analyses in the rows below. The second row (FTD<CN) shows FA reductions
in FTD relative to cognitively normal involving the anterior frontal and temporal brain. The third row (AD<CN) shows the regional FA
reductions in Alzheimer’s disease relative to cognitively normal involving only a few regions in left anterior cingulum and bilateral
uncinate ﬁbres. The fourth row (FTD<AD) shows FA reductions in FTD relative to Alzheimer’s disease indicating FTD had signiﬁcantly
lower FA in vast regions of bilateral frontal lobes including anterior corpus callosum, bilateral anterior cingulum, uncinate ﬁbres and
anterior limb of internal capsule. Last row (T1WI) depicts the anatomical locations on a T1-weighted brain template. The areas with
signiﬁcantly decreased FA values are marked in warm colours with threshold PFDR = 0.05.
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these ﬁndings are also consistent with histopathological evidence
of tau protein deposition in white matter of FTD (Schoﬁeld et al.,
2003). Notably, we found substantial FA reduction in the bilateral
descending cingulum, which is a major limbic ﬁbre loop in the
medial temporal lobe. The ﬁnding is consistent with reports from
structural MRI studies of neurodegeneration of the paralimbic
network in FTD (Rabinovici et al., 2007–08; Seeley et al., 2008),
but has not been observed in DTI studies before.
Our ﬁndings of FA reductions in the parietal and temporal
regions in Alzheimer’s disease are in agreement with several
other DTI studies (Takahashi et al., 2002; Fellgiebel et al., 2004;
Naggara et al., 2006; Taoka et al., 2006; Xie et al., 2006; Stahl
et al., 2007; Teipel et al., 2007; Salat et al., in press). DTI abnor-
malities in ﬁbres located deep in the posterior white matter, such
as the left posterior cingulum and the posterior corpus callosum
have consistently been reported for Alzheimer’s disease and even
for mild cognitive impairment (MCI) (Fellgiebel et al., 2005;
Medina et al., 2006; Stahl et al., 2007; Zhang et al., 2007;
Parente et al., 2008), which is a diagnostic category that will
include many subjects with a preclinical stage of Alzheimer’s
disease. In addition, we found abnormalities in the descending
branch of cingulum (i.e. the parahippocampal ﬁbre), consistent
with histological, structural and metabolic studies suggesting that
the medial temporal region is particularly vulnerable to Alzheimer’s
pathology (see review papers: Anderson et al., 2005; Drzezga,
2008; Ries et al., 2008). Moreover, the observation of FA reduc-
tion in the descending cingulum replicates our previous DTI results
in an entirely different population of Alzheimer’s disease and MCI
patients (Zhang et al., 2007). More recently, altered diffusion
properties of parahippocampal white matter in Alzheimer’s disease
were found even in absence of signiﬁcant grey matter degenera-
tion as measured by hippocampal atrophy (Salat et al., in press).
These ﬁndings imply that disintegration of the parahippocampal
ﬁbres is a systematic and potentially early marker of incipient
Alzheimer’s disease. However, the pathological underpinning
of FA changes in white matter in Alzheimer’s disease remains elu-
sive with several explanations possible. One possibility is that
the degeneration of white matter is secondary to grey matter
pathology. Alzheimer’s disease is thought to begin in grey
matter with deposition of b-amyloid around neuronal cell bodies.
The disease is also associated with accumulation of tau protein in
Figure 6 Coronal view of the regional FA reductions in the posterior brain comparing between groups: the top row indicates regions of
the tracts of interest (TOIs) analysis for comparison with the voxel-wise analyses in the rows below. The second row (FTD<CN) shows
FA reductions in FTD relative to cognitively normal involving the anterior frontal and temporal brain. FTD compared to cognitively
normal had widely distributed changes involving the posterior brain (but not as strong as anterior brain) including posterior corpus
callosum, bilateral posterior cingulum, descending cingulum ﬁbres, as well as ﬁbres in superior longitudinal fascicules. The third row
(AD<CN) shows the regional FA reductions in Alzheimer’s disease relative to cognitively normal involving a few regions in left posterior
cingulum and left descending cingulum. The fourth row (FTD<AD) shows FA reductions in FTD relative to Alzheimer’s disease
indicating FTD had signiﬁcantly lower FA in regions of the bilateral superior longitudinal fascicules and inferior thalamic areas. The last
row (T1WI) depicts the anatomical locations on a T1-weighted brain template. The areas with signiﬁcantly decreased FA values are
marked in warm colours with threshold PFDR = 0.05.
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lead to neurodegeneration including loss of axons within asso-
ciated white matter tracks. This white matter degradation can
then be detected via FA reductions measured by DTI. An alterna-
tive explanation is that white matter degeneration is a direct
consequence of Alzheimer’s pathology. Braak et al. (2000)
hypothesized that as brain development takes place, regions that
become myelinated later in the process, such as cortical association
areas, have fewer oligodendrocytes supporting greater numbers of
axons compared to regions that become myelinated earlier
(primary sensorimotor regions). Oligodendrocytes have particularly
high metabolic demands in the cortical association areas to main-
tain the distributed network of their axons, which makes these
axons more susceptible to pathological processes such as oxidative
stress (Bartzokis, 2004). These and other changes may lead to the
diminished white matter integrity in the association cortical
regions. Longitudinal studies, using DTI and cortical mapping
together, are needed to investigate the relationship between
white matter and grey matter changes in more detail.
Relative to Alzheimer’s disease, FTD was associated with
markedly reduced FA in the frontal brain regions. This ﬁnding is
consistent with several structural and functional imaging studies
which reported greater grey matter loss and reduced cerebral
blood ﬂow in frontal brain regions in FTD when compared to
Alzheimer’s disease (Julin et al., 1995; Kitagaki et al., 1998;
Varma et al., 2002; Varrone et al., 2002). Taking these DTI,
structural and functional ﬁndings in FTD together, the results
emphasize an association between white matter degradation and
cortical abnormalities in FTD. In contrast, Alzheimer’s disease
showed no signiﬁcant FA reductions relative to FTD. This obser-
vation is surprising because several structural and functional
imaging studies of Alzheimer’s disease reported substantial
abnormalities in posterior brain regions in Alzheimer’s disease
relative to FTD (Varrone et al., 2002; Du et al., 2006). One pos-
sible explanation is that white matter and grey matter are affected
differently in Alzheimer’s disease and FTD throughout the course
of the disease. Our ongoing studies hope to better elucidate the
relationship between grey matter and white matter changes in
Alzheimer’s disease and FTD. Another possibility, which cannot
be ruled out is that the patients diagnosed with Alzheimer’s
disease in this study were at an earlier stage of the disease and
less impaired than the FTD patients. It is difﬁcult to compare
disease severity in two different disorders which have quite differ-
ent symptomatology. It is possible that these patients with
Alzheimer’s disease will eventually exhibit regions of reduced FA
relative to FTD as the disease progresses. Prospective studies of
FTD and Alzheimer’s disease are needed to resolve this issue.
Examination of regional alterations in various diffusion
parameters, including radial and Dax in addition to anisotropy,
showed distinct zones of alterations that potentially stemmed
from different underlying pathological processes. For example,
radial and Dax of the uncinate ﬁbres was substantially higher in
FTD than in Alzheimer’s disease where most regions of reduced
FA values showed also increased Dra. On the other hand, differ-
ences in diffusion anisotropy of the anterior corpus callosum ﬁbres
between FTD and Alzheimer’s disease disappeared when analysed
in terms of Dra. These results suggest that some disease speciﬁcity
may be obtained by further examination of different DTI eigen-
values. Diffusion studies in animals suggest that increased Dra can
be associated with myelin damage (Song et al., 2002; Harsan
et al., 2006). Accordingly, our ﬁndings of increased Dra in some
regions in FTD and Alzheimer’s disease, including the uncinate
ﬁbres, could reﬂect processes of demyelination. In contrast,
demyelination would not explain the FA differences in anterior
corpus callosum ﬁbres between FTD and Alzheimer’s disease,
since Dra was not signiﬁcantly different. However, the interpreta-
tion of DTI indices with respect to pathology is notoriously ambig-
uous and more validation studies to the underlying causes of DTI
changes are necessary.
Several limitations of our study ought to be mentioned. First,
the clinical diagnoses were not conﬁrmed by autopsy and, there-
fore, the pathological processes underlying the DTI alterations may
not be associated with FTD and Alzheimer’s disease. In particular,
FTD, which is one of several variants of frontotemporal lobar
degeneration that have different aetiologies, suffers from diag-
nostic uncertainty. Consequently, the pattern of DTI changes
may vary among FTD patients with different aetiologies. Second,
although the groups were matched for WMSH severity and
regions including WMSH were avoided in analysis, WMSH due
to cerebrovascular disease may have affected FA and the other
DTI measures. The relation between ﬁbre integrity and cerebro-
vascular disease needs to be explored further. Another concern is
that large variations of brain shape in older subjects limited the
ability to achieve spatial normalization of white matter regions
across the subjects. This is particularly critical as cortical and
ventricular shapes may have driven image registration. Some FA
changes, especially in regions surrounding the ventricles as seen
in Figs 5 and 6, could be a result of artefacts due to image mis-
registration and underlying variations of brain shapes. The use of
more sophisticated algorithms for DTI registration such as Tract-
Based Spatial Statistics (TBSS) (Smith et al., 2006) or dense feature
deformation morphometry (Studholme, 2008) could lead to differ-
ent results. Further studies involving a larger number of patients
and autopsied conﬁrmation of the pathology are needed to
support our results.
In summary, the regional DTI alterations suggest that FTD
and Alzheimer’s disease are each associated with a characteristic
distribution of white matter degradation. The results also suggest a
greater vulnerability of white matter in FTD than in Alzheimer’s
disease. DTI may provide additional diagnostic information to
distinguish Alzheimer’s disease from FTD.
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